We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regulation Could Cut Time to Clinical Trials in Brazil
Regulation Could Cut Time to Clinical Trials in Brazil
Drugmakers could see their wait time to begin clinical trials in Brazil cut by more than a third under a proposed regulation calling for protocols to be reviewed in their entirety, rather in stages, which is the current policy.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor